2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice GuidelinesJosé Luis Zamorano, Thomas Suter, Gregory Y.H. Lip et al.|European Heart Journal|2016Cited by 2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice GuidelinesJosé Luis Zamorano, Stephan Windecker, Patrizio Lancellotti et al.|European Journal of Heart Failure|2016Cited by 1.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal - Cardiovascular Imaging|2022Cited by 486
Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Alexander R Lyon, Christian Mueller et al.|European Journal of Heart Failure|2020Cited by 344